Inventor · disambiguated record
Florian Puehler
Also filed as: PUEHLER FLORIAN · PÜEHLER FLORIAN
12 granted patents·15 pending applications·38 citations·filing 2005–2015
84Inventor score
Top patents by PatentIndex Score
27 records- 0192US9320737B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted Apr 26, 2016·27 cites·12 claims
- 0280US9382255B2Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitorsBayer Pharma AG·Filed 2013·Granted Jul 5, 2016·3 cites·9 claims
- 0375US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 0474US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 0572US9540392B2ThienopyrimidinesBayer Pharma AG·Filed 2013·Granted Jan 10, 2017·2 cites·10 claims
- 0660US2009208495A1Anti-tumor effective paramyxovirusBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 0754US2009082328A1Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityBAYER HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 0850US2015252047A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseasesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 0949US2011071125A1Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityRUDOLPH JOACHIM·Filed 2008·Application pending·0 cites
- 1047US9675612B2Substituted thiazolopyrimidinesBayer Pharma AG·Filed 2014·Granted Jun 13, 2017·0 cites·11 claims
- 1145US2016297833A1Thienopyrimidines as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1245US2008206201A1Recombinant Newcastle Disease VirusBEIER RUDOLF·Filed 2005·Application pending·0 cites
- 1344US2016287589A1Substituted-imidazopyridazinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1444US2016159789A1Substituted pyrazolopyridinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1543US9783543B2AminoimidazopyridazinesBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·0 cites·8 claims
- 1643US9745304B2Amidoimidazopyridazines as MKNK-1 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·0 cites·9 claims
- 1743US2016272635A1Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinasesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1843US2015133426A1Substituted pyrrolopyrimidinesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1942US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 2042US9777004B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2013·Granted Oct 3, 2017·0 cites·9 claims
- 2142US2015218173A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2242US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2341US9643974B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·0 cites·9 claims
- 2438US2011020282A1Recombinant newcastle disease virusBEIER RUDOLF·Filed 2010·Application pending·0 cites
- 2535US10214545B2Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disordersBayer Pharma AG·Filed 2015·Granted Feb 26, 2019·0 cites·21 claims
- 2631US2017107212A1Novel compoundsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2731US2017114070A1Inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Florian Puehler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →